Africa Nonwoven Fabric Market Report: Market Size & Forecast 2026

The Middle East and Africa nonwoven fabrics market encompasses engineered textile products manufactured through bonded fiber processes rather than traditional weaving or knitting. Valued at approximately $2.181 billion in 2026, having grown from approximately $2.13 billion in 2025, the market spans a wide range of applications from disposable hygiene products to durable industrial materials. The region's market is supported by growing manufacturing capabilities and increasing local production capacity across key producing nations.

Healthcare infrastructure expansion across African nations is a primary catalyst, as nonwoven fabrics form essential components in surgical gowns, drapes, and wound care products. Rising hygiene awareness and increasing disposable income levels are driving greater consumption of disposable hygiene products made from nonwoven materials. Industrial applications, including filtration, construction, and automotive uses, are also contributing to sustained market growth across the region.

The market is segmented by product type into disposable and durable nonwoven categories, with hygiene and industrial applications representing the largest end-use segments. Material types include polypropylene, polyester, and natural fiber-based nonwovens, while production technologies span spunbond, dry laid, and other bonding methods. Geographically, the Gulf Cooperation Council countries, South Africa, Egypt, and Nigeria represent key markets, with varying growth rates reflecting different stages of industrialization and healthcare development.

What are the recent trends and outlook?

Sustainable and biodegradable nonwoven materials are gaining traction as environmental regulations tighten across European-influenced markets in North and Southern Africa. Technological advancements in spunbond and meltblown processes are enabling higher-quality production at competitive costs, expanding the addressable market. The market is expected to maintain its 2.4% CAGR trajectory through 2031, with accelerated growth potential in underserved Sub-Saharan markets as healthcare and hygiene infrastructure continues to develop.